General Information of the Compound
Compound ID
CP0520921
Compound Name
5-Methyl-2-phenyl-2H,5H-[1,2,4]triazolo[4,3-a]quinoxaline-1,4-dione
    Show/Hide
Structure
Formula
C16H12N4O2
Molecular Weight
292.298
Canonical SMILES
Cn1c2ccccc2n2c(nn(-c3ccccc3)c2=O)c1=O
    Show/Hide
InChI
InChI=1S/C16H12N4O2/c1-18-12-9-5-6-10-13(12)19-14(15(18)21)17-20(16(19)22)11-7-3-2-4-8-11/h2-10H,1H3
    Show/Hide
InChIKey
OLLSKNKUQGSHMV-UHFFFAOYSA-N
Physicochemical Property
logP
1.3371
Rotatable Bonds
1
Heavy Atom Count
22
Polar Areas
61.3
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 10732372
SID: 15768343
ChEMBL ID
CHEMBL16510
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01279, Adenosine receptor A3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 36.6 nM
   TI
   LI
   LO
   TS